市场调查报告书
商品编码
1276353
感染监测解决方案全球市场规模,份额和行业趋势分析:按产品/服务(软件(本地,基于 Web,的软件),服务),最终用户,区域展望/预测,2023-2029Global Infection Surveillance Solutions Market Size, Share & Industry Trends Analysis Report By Product & Services (Software (On-premise and Web-based Software) and Services), By End User, By Regional Outlook and Forecast, 2023 - 2029 |
到 2029 年,感染监测解决方案市场规模预计将达到 13 亿美元,预测期内復合年增长率为 12.9%。
随着医疗保健成本的上升,对感染监测解决方案的需求预计也会增加。 此外,由于有利可图的政府举措,市场正在扩大。 此外,IT系统的分析处理能力得到提升,随着IT系统的技术发展,我们支持创建用于医疗领域的分析解决方案和感染监测解决方案。
将算法与专门的数据挖掘工具、电子病历和全自动 HAI 监控结合使用,使用基于临床支持的信息来帮助检测特定的临床术语,这些都是其中的一些方法。 感染监测解决方案市场正在经历显着扩张,原因有多种因素,例如手术次数增加和政府为避免 HAI 制定的法规。
COVID-19 影响分析
COVID-19 大流行的爆发有利于感染监测解决方案市场。 COVID-19 大流行使全球医疗保健系统不堪重负,并增加了 COVID-19 患者感染医疗保健相关感染的机会。 卫生设施的人口减少是由于 COVID 阳性患者的急剧增加和病毒传播率的飙升造成的。 此外,由于传染病控制意识的增强,后疫情时期对感染监测解决方案的需求也越来越大。
市场增长因素
扩大抗生素管理计划的采用
感染控制和流行病学 (APIC) 旨在阻止 HAI 数量的增加。 全球健康和发展关注的一个问题是抗菌素耐药性 (AMR)。 据世界卫生组织称,抗菌素耐药性是全球十大对人类健康的危害之一。 2015 年,世卫组织推出了全球抗微生物药物耐药性和使用监测系统(GLASS),该系统整合了人类 AMR 和药物使用监测信息。 为了满足医疗机构的需求,一些市场进入者正在推出抗生素管理监测解决方案。 基于此,感染监测解决方案市场预计将支持市场增长。
新兴国家的巨大增长机会
预计印度、中国、巴西、俄罗斯、拉丁美洲和东南亚等发展中经济体的感染监测解决方案市场潜力巨大。 这是因为一半以上的人口集中在印度和中国,而世界上很大一部分人口都集中在这些地区。 在这些国家,由于人均收入的增加、医疗意识的提高、医院和诊所数量的增加以及患者数量的增加,对更好的医疗保健服务的需求也在增加。 这些国家的医疗器械製造受到融合感染控制技术的新市场的出现的推动,市场扩张的前景看好。
市场製约因素
小型组织的引进成本太高
高互操作性和部署成本使得面向医疗保健提供商的 IT 软件解决方案部署起来既困难又昂贵。 在医疗领域,互联网接入整合在小型医疗企业中较为常见,因为不同网络难以搭建,无线化的可能性很小,并且需要严格的安全措施来防止数据洩露,这变得困难。 此外,感染监控软件非常昂贵。 此外,为售后设备集成构建定制接口需要额外的验证和确认,增加了医疗保健组织的总拥有成本。 较小的医院和医疗集团无力承担这些额外费用,因此无法实施该解决方案。 因此,感染监测解决方案市场的增长预计将放缓。
产品和服务的前景
感染监测解决方案市场按产品和服务细分为软件和服务。 到 2022 年,服务部门将在感染监测解决方案市场中占据重要的收入份额。 这是因为感染监控软件需要持续的产品更新和技术支持。 客户(医疗机构)需要访问供应商公司的技术知识库、产品支持团队的帮助以及应用程序管理技能,从而推动产品支持和维护服务的扩展。
软件展望
按软件划分,感染监控解决方案市场分为本地软件和基于网络的软件。 到 2022 年,感染监测解决方案市场在内部部署部分的收入份额最大。 这背后是对安全访问医疗 IT 系统的需求,以及降低数据洩露和外部攻击风险的需求。 因此,许多医疗保健公司青睐本地软件解决方案来确保患者数据的安全。 重用现有存储和服务器的能力是一个额外的好处,特别是对于从一个系统升级或迁移到另一个系统的公司而言。
最终用户视角
按最终用户划分,感染监测解决方案市场分为医院、长期护理机构等。 到 2022 年,感染监测解决方案市场将由医院部门主导。 考虑到 HAI 发生频率的增加以及相关利益相关者的经济负担,医院正在引入感染控制产品和服务。 此外,由于患者人数众多和手术部位感染 (SSI) 发生率上升,市场正在扩大。
区域展望
按地区划分,分析了北美、欧洲、亚太地区和 LAMEA 的感染监测解决方案市场。 到 2022 年,北美地区将以最高的收入份额引领感染监测解决方案市场。 由于医疗保健 IT 解决方案的激增以遏制不断上升的医疗成本、医疗机构的快速整合以及美国 HAIs 患病率上升等因素,北美市场正在发生重大变化。 北美大量感染监测解决方案的另一个重要方面是该地区的商业财富。
合作和收购是市场进入者采取的主要策略。 根据基数矩阵的分析,甲骨文公司在感染监控解决方案市场处于领先地位。 Becton、Dickinson and Company、Wolters Kluwer N.V. 和 Baxter International, Inc. 等公司是感染监测解决方案市场的领先创新者。
这份市场研究报告涵盖了对市场主要利益相关者的分析。 本报告介绍的主要公司有 Becton, Dickinson and Company、Oracle Corporation (Cerner Corporation)、Wolters Kluwer N.V.、BioMerieux S.A.、Baxter International, Inc. Harris Healthcare (Constellation Software, Inc.)、Securitas AB、OSI Systems, Inc. (Spacelabs Healthcare)、Gojo Industries, Inc. 和 Merative L.P.(Francisco Partners)。
The Global Infection Surveillance Solutions Market size is expected to reach $1.3 billion by 2029, rising at a market growth of 12.9% CAGR during the forecast period.
The goal of infection surveillance solutions is to accurately apply preventive actions by continuously monitoring and interpreting data related to health. Data from infection surveillance is used to assess and guard against the harm preventable infections can do to patients and healthcare professionals. Hand hygiene, injection safety, antimicrobial resistance, surgical site infections, and hospitals that are open both during and after emergencies are all impacted by infection prevention and control.
During the projected period, key factors driving market growth include increasing antibiotic resistance among bacteria and increasing usage of automation in healthcare settings. In addition, increased hospital stays result from increased surgical procedures performed globally. There will consequently be an increase in the number of patients who contract HAIs.
The demand for solutions for infection surveillance is also anticipated to increase as healthcare costs rise. The market has also been expanding as a result of advantageous government initiatives. Additionally, the ability of IT systems to process analytics has increased, and this, together with technological developments in IT systems, is assisting in the creation of analytical or infection surveillance solutions for use in the healthcare sector.
The use of algorithms with specialized data mining tools, electronic medical records, and completely automated HAI surveillance using clinical support-based information that aids in the detection of specific clinical words are some of these methods. The market for infection surveillance solutions is experiencing significant expansion due to several causes, including increased surgeries and government rules to avoid HAIs.
COVID-19 Impact Analysis
The COVID-19 pandemic outbreak was beneficial for the market for infection control surveillance solutions. The COVID-19 pandemic has put a strain on the global healthcare system and raised the chance of COVID-19 patients contracting a healthcare-associated infection. The overpopulation of healthcare facilities was caused by the exponential growth in COVID-positive patients and the fast-increasing rate of viral transmission. In addition, the increased awareness of infection control resulted in increased demand for infection surveillance solutions even during the post-pandemic period.
Market Growth Factor
Growing adoption of antimicrobial stewardship programs
Infection Control and Epidemiology (APIC) aims to stop the rising number of HAIs. A concern to world health and development is antimicrobial resistance (AMR). According to the WHO, one of the top 10 worldwide public health hazards to humanity is AMR. WHO introduced the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015, integrating information from human AMR and drug use surveillance. To meet the demands of healthcare facilities, several market participants have come up with surveillance solutions for antimicrobial stewardship. In light of this, the infection surveillance solutions market is predicted to support the market growth.
Significant growth opportunities in emerging markets
In nations with rising economies like India, China, Brazil, Russia, and those in Latin America and Southeast Asia, there are likely to be significant potential prospects for the infection surveillance solutions market. This is because a significant amount of the world's population, with more than half living in India and China, is concentrated in these areas. The need for better healthcare services has grown in these nations due to rising per capita income, rising healthcare awareness, an increase in hospitals & clinics, and a large patient population. The manufacturing of medical devices in these nations is being pushed by the rise of new markets to embrace infection control technology, creating prospects for market expansion.
Market Restraining Factor
Cost of deployment is unaffordable for small organizations
The high cost of interoperability and deployment makes it difficult and expensive to implement IT software solutions for healthcare organizations. Smaller healthcare businesses have more difficulty integrating internet access since it is difficult to set up different networks in healthcare contexts, there are few wireless possibilities, and rigorous security measures are required to prevent data breaches. In addition to this, infection surveillance software can be quite pricey. In addition, the construction of a bespoke interface for the integration of a device after sales involves additional validation and verification, which adds to the overall cost of ownership for healthcare providers. Smaller hospitals & healthcare groups are unable to pay these additional costs and hence do deploy the solutions. Due to this, the infection surveillance solutions market is predicted to witness slow growth.
Product & Services Outlook
By product & services, the infection surveillance solutions market is segmented into software and services. The services segment covered a substantial revenue share in the infection surveillance solutions market in 2022. This is because infection surveillance software needs ongoing product updates and technical assistance. Clients' (healthcare providers') need for access to the vendor company's technical knowledge base, assistance from its product support team, and the acquisition of application management skills are fuelling the expansion of the product support & maintenance services.
Software Outlook
Under software, the infection surveillance solutions market is divided into on-premise software and web-based software. In 2022, the on-premise segment witnessed the largest revenue share in the infection surveillance solutions market. This is due to the necessity for safe access to healthcare IT systems as well as the need to reduce the danger of data breaches and outside attacks. As a result, many healthcare businesses favor on-premise software solutions to guarantee the security of their patient data. Reusing existing storage and server gear is an additional advantage, especially for businesses upgrading or migrating from one system to another.
End User Outlook
By end-user, the infection surveillance solutions market is categorized into hospitals, long-term care facilities and others. In 2022, the hospital segment registered the maximum revenue share in the infection surveillance solutions market. Hospitals have adopted infection control goods and services due to the increasing frequency of HAIs and the associated financial burden on stakeholders. The market is also expanding due to the high patient volume and rising incidence of surgical site infections (SSIs).
Regional Outlook
Region wise, the infection surveillance solutions market is analyzed across North America, Europe, Asia Pacific and LAMEA. In 2022, the North America region led the infection surveillance solutions market by generating the highest revenue share. Due to factors like the widespread use of healthcare IT solutions to contain the rise in healthcare costs, rapid consolidation of healthcare providers, and the rising prevalence of HAIs in the US, the market in North America is seeing major changes. Another important aspect of North America's significant market share in infection surveillance solutions is the abundance of businesses in the region.
The major strategies followed by the market participants are Partnerships and Acquisition. Based on the Analysis presented in the Cardinal matrix; Oracle Corporation is the forerunner in the Infection Surveillance Solutions Market. Companies such as Becton, Dickinson and Company, Wolters Kluwer N.V., and Baxter International, Inc. are some of the key innovators in the Infection Surveillance Solutions Market.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Becton, Dickinson and Company, Oracle Corporation (Cerner Corporation), Wolters Kluwer N.V., BioMerieux S.A., Baxter International, Inc., Harris Healthcare (Constellation Software, Inc.), Securitas AB, OSI Systems, Inc. (Spacelabs Healthcare), Gojo Industries, Inc. and Merative L.P. (Francisco Partners)
Recent Strategies Deployed in Infection Surveillance Solutions Market
Partnerships, Collaborations and Agreements:
Nov-2022: Wolters partnered with Microsoft, a technology corporation, to enable healthcare organizations to offer better care and service to their customers. Through this acquisition, integrating Microsoft Azure cloud platform with Kluwer's powerful software services for healthcare would allow Wolters' to support virtual care providers and payers to generate and deploy offerings helpful in keeping engaged their patients and members.
Nov-2022: Oracle Cerner came into partnership with Labcorp, a life-science enterprise, for the management of hospital-based laboratories. Through this partnership, Labcorp's diagnostic information capabilities would empower Cerner to advance Cerner's offering facilitating to eliminate manual processes in the labs easing out the information sharing all over the health system, enabling to make quick diagnostic decisions and enhancing patient care.
Sep-2022: BioMerieux announced a partnership with BrightInsight, Inc., a medtech-regulated digital health solutions provider, to offer a Clinical Digital Solution for diagnostics allowing improved clinical decision backing for disease domains all over the diagnostic tests. Utilizing the capabilities of compliant BrightInsight Platform and BrightInsight Disease Management offering, delivering high-level regulated digital health software as a Medical Device categorization, BioMerieux would be able to offer healthcare sector enhanced clinical workflows and contextualize disease awareness and empower clinicians to make actionable informed decisions. Moreover, the partnership would enable BioMerieux to make developments in Clinical Digital solutions for diagnostics.
Jun-2022: BD partnered with Mayo Clinic Platform, a patientcare technological solutions provider, for providing access to patient data from Mayo Clinic Platform. With this partnership, utilizing the power of Mayo Clinic's in delivering advance dataset, and historical data for predictive modeling would enable BD to deliver services that increase clinical trials efficiency and access to patient data utilizing Mayo Clinic Platform. Moreover, Mayo Clinic's data would support BD to advance its product and smoothen medical device regulatory submissions.
Aug-2021: Baxter signed a partnership with Amazon Web Services (AWS), an IT service management enterprise, to enhance enterprise digital transformation. Through this partnership, leveraging the power of the cloud services suite offered by AWS would allow Baxter to propel the growth of Baxter's technology infrastructure enhancing the potential of healthcare data and leading to better patient care.
Product Launches and Product Expansions:
Apr-2023: BioMerieux announced the launch of BIOFIRE FIREWORKS, a powerful software with a user-friendly interface, personalized filters, and smooth integration, for BIOFIRE Systems for making laboratory services and data-based decisions enhanced and quick. BIOFIRE FIREWORKS would be an introduction to the BIOMERIEUX VISION SUITE-a portfolio of Data and IT Solutions for delivering enhanced efficiency and productivity to laboratories across the world. Integrating the potential of all BIOFIRE FILMARRAY systems into one centralized place, the software would provide real-time connectivity to both central and off-site labs. BIOFIRE FILMARRAY systems offer data access from anywhere and at any time improving laboratories workflow to easily manage all its operations delivering better patient care.
Sep-2022: Becton Dickinson announced the launch of BD Research Cloud, a cloud-centered software tool to smoothen flow cytometry workflow helpful in empowering scientists the ability of experimentation with faster time to insights all over immunology, virology, oncology, and infectious disease monitoring. BD Research Cloud would enable users to combine all flow cytometry workflow steps beneficial in creating reagent panels, integrate instruments with data analysis software, store experimental data. The new offering would be a robust and all-inclusive platform connecting instruments, reagents, and data analysis, supporting scientists to potentially discover research for drug development.
May-2022: BD launched automated, infectious disease molecular diagnostics platform. The powerful BD COR™ MX instrument would be a latest analytic instrument option supporting BD COR System. The offering would integrate and automate the entire molecular laboratory workflow starting from sample processing to diagnostic test result for sizeable labs, mitigating the requirement for sorting specimens.
Acquisitions and Mergers:
Jul-2022: BD acquired Parata Systems, a pharmacy automation solutions provider, for offering patient safety solutions. With this acquisition, Parata's expertise in delivering pharmacy automation services would be combined with BD's transformative solutions capabilities to develop suite of advanced pharmacy automation offerings strengthening a growing network of pharmacies to lower costs, improve patient safety and patient experience to serve retail, hospital, and pharmacies.
Apr-2022: BioMerieux S.A. completed the acquisition of Specific Diagnostics, a fast AST solution focused organization, to combat the antimicrobial resistance-a threat with infections from antibiotic resistant pathogens. With this acquisition, integration of Specific Diagnostics' REVEAL Rapid AST system into BioMerieux's suite of microbiology would provide strength to clinicians and laboratories offering enhanced patient outcomes supporting broad distribution network.
Dec-2021: BD took over Scanwell Health, at-home medical testing services provider, for broadening and scaling up the digital at-home medical testing. With this acquisition, leveraging the power of Scanwell Health in offering at-home medical testing facilities would boost BD's capability to deliver its customers at-home diagnostic tests for an extensive range of infectious diseases, including group A strep, Covid-19/influenza A+B, alongside scaling the digital at-home medical testing.
Dec-2021: Baxter International acquired Hillrom, a medical technology provider, to better serve patients, and clinicians. Through this acquisition, combining the Baxter's connectivity technology with Hillrom's Medical Diagnostic Equipment offerings would support Baxter to deliver advanced digital healthcare and better patient care services beneficial in reducing cost and enhancing workflow efficiency.
Market Segments covered in the Report:
By Product & Services
By End User
By Geography
Companies Profiled
Unique Offerings from KBV Research
List of Figures